Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07364617
What this trial is testing

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Who this might be right for
Graft vs Host Disease
Chang Gung Memorial Hospital 35
Early research (Phase 1)Looking for participantsNCT05443425
What this trial is testing

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Acute Graft Versus Host DiseaseHematopoietic and Lymphoid System Neoplasm
City of Hope Medical Center 18
Post-approval studies (Phase 4)Study completedNCT00361140
What this trial is testing

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersLeukemia, Lymphocytic+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Large-scale testing (Phase 3)Study completedNCT06791746
What this trial is testing

Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT

Who this might be right for
Stem Cell Transplant ComplicationsOral Mucositis
Zhejiang University 388
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Not applicableEnrolling By InvitationNCT06912347
What this trial is testing

Acupoint Application With Herbal Fumigation and Wash for Preventing Diarrhea-induced Perianal Infection in Allo-HSCT Patients

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Ruijin Hospital 180
Testing effectiveness (Phase 2)Ended earlyNCT01532635
What this trial is testing

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Who this might be right for
Hematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Testing effectiveness (Phase 2)WithdrawnNCT04312789
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

Who this might be right for
Platelet Disorder
Ayman Saad
Early research (Phase 1)Study completedNCT03932643
What this trial is testing

ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University of Nebraska 20
Testing effectiveness (Phase 2)Ended earlyNCT00720850
What this trial is testing

Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Who this might be right for
Myelodysplastic SyndromesAcute Myelogenous Leukemia
Technische Universität Dresden 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03301168
What this trial is testing

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Acute Myeloid (AML), ChildLymphoma, Non-Hodgkin+6 more
Bellicum Pharmaceuticals 120
Testing effectiveness (Phase 2)Looking for participantsNCT06481735
What this trial is testing

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Who this might be right for
Acute Lymphocytic Leukemia
Chinese PLA General Hospital 30
Not applicableUnknownNCT00450268
What this trial is testing

Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft Versus Host Disease
Technische Universität Dresden 50
Testing effectiveness (Phase 2)Looking for participantsNCT07535645
What this trial is testing

Baricitinib for Post-HSCT Persistent Thrombocytopenia

Who this might be right for
Persistent ThrombocytopeniaAllogeneic Hematopoietic Stem Cell Transplantation
Peking University People's Hospital 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07757672
What this trial is testing

Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.

Who this might be right for
AML (Acute Myelogenous LeukemiaHSCT
Institute of Hematology & Blood Diseases Hospital, China 50
Large-scale testing (Phase 3)UnknownNCT03662087
What this trial is testing

HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

Who this might be right for
Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
Nanfang Hospital, Southern Medical University 100
Testing effectiveness (Phase 2)Study completedNCT01835587
What this trial is testing

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 31
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Next Page